Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
To explore the expression levels of galectin-3 in colorectal cancer and the association between galectin-3 and its clinical pathological parameters, as well as the prognosis of colorectal cancer patients.
Main Authors: | Tao Liu, Jin Li, Dechun Li, Hongqiang Yang, Changhua Kou, Guijun Lei |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2017-07-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2017-0032 |
Similar Items
-
Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
by: Fei Kong, et al.
Published: (2020-09-01) -
Overexpression of DSCR1 prevents proliferation and predicts favorable prognosis in colorectal cancer patients
by: Wen-Xiang Li, et al.
Published: (2021-04-01) -
CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study
by: Feng Huang, et al.
Published: (2020-10-01) -
Correlation of CD47 Expression with Adverse Clinicopathologic Features and an Unfavorable Prognosis in Colorectal Adenocarcinoma
by: Hyunsung Kim, et al.
Published: (2021-04-01) -
Loss of YY1 expression predicts unfavorable prognosis in stage III colorectal cancer
by: Hyunsung Kim, et al.
Published: (2021-01-01)